ArticleJournal of clinical pharmacology2019

A Phase 1, Multiple-Dose Study of Vedolizumab in Japanese Patients With Ulcerative Colitis.

Kiyonori Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.